These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1990625)
21. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. Schmid C; Heemann U; Azuma H; Tilney NL Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053 [No Abstract] [Full Text] [Related]
22. The importance of donor MHC compatibility in the allo- and autoimmune destruction of islet grafts in the BB rat. Stegall MD; Chabot JA; Tezuka K; Reemtsma K; Hardy MA Transplant Proc; 1990 Apr; 22(2):844. PubMed ID: 2109414 [No Abstract] [Full Text] [Related]
29. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease? Hauptman PJ; Nakagawa T; Tanaka H; Libby P J Heart Lung Transplant; 1995; 14(6 Pt 2):S173-80. PubMed ID: 8719481 [No Abstract] [Full Text] [Related]
30. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. Koskinen P; Lemström K; Bruggeman C; Lautenschlager I; Häyry P Am J Pathol; 1994 Jan; 144(1):41-50. PubMed ID: 8291611 [TBL] [Abstract][Full Text] [Related]
31. Infiltration pattern of rat heart allografts during rejection. Westra AL; Romaniuk A; Ryffa T; Wildevuur CR; Nieuwenhuis P Transplant Proc; 1987 Feb; 19(1 Pt 1):374. PubMed ID: 3274787 [No Abstract] [Full Text] [Related]
32. Assessment of troponin-T for detection of cardiac rejection in a rat model. Walpoth BH; Tschopp A; Peheim E; Schaffner T; Althaus U Transplant Proc; 1995 Jun; 27(3):2084-7. PubMed ID: 7792894 [No Abstract] [Full Text] [Related]
34. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats. Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098 [TBL] [Abstract][Full Text] [Related]
35. Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. Meiser BM; Wolf S; Devens C; Wenke K; Thiery J; Kreuzer E; Hammer C; Billingham ME; Reichart B Transplant Proc; 1992 Oct; 24(5):1671-2. PubMed ID: 1384201 [No Abstract] [Full Text] [Related]
36. Allogeneic heart transplantation activates alloreactive NK cells. Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185 [TBL] [Abstract][Full Text] [Related]
37. Lymphocyte subsets in heart allograft rejection in a rat model: effect of in vitro generated suppressor cells. Lowry RP; Shadur CA; Duarte A; Strom TB; Carpenter CB Transplant Proc; 1981 Jun; 13(2):1428-31. PubMed ID: 6454287 [No Abstract] [Full Text] [Related]
38. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine. Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435 [TBL] [Abstract][Full Text] [Related]
39. Endothelial cell antigens associated with accelerated cardiac graft rejection in the rat. Yasunaga C; Cramer DV; Tuso PJ; Fujioka H; Barnett M; Yanaga K; Sugimachi K; Makowka L Transplant Proc; 1995 Feb; 27(1):495-6. PubMed ID: 7879075 [No Abstract] [Full Text] [Related]
40. Inhibition of graft coronary arteriosclerosis after heart transplantation. Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]